22 results
Thumbnail

D2.342 - Changes of MMP-9 and MMP-12 in response of acute viral infection in virtual model of macrophages

Thumbnail

D2.343 - Use of IDDA 2.1 score in Common Variable Immunodeficiency (CVID): a single center experience

Thumbnail

D2.344 - Unraveling the Mysteries of Chronic Granulomatous Disease: A Case of detected Protein Deficiency Amidst Negative Genetic Screening

Thumbnail

D2.345 - Conformations of HVEM engaged in its Trans and Cis interactions are caused by two kinds of post-translational folding

Thumbnail

D2.346 - Assessment of the safety of allogenic natural killer cells in the treatment of metastatic colon cancer

Thumbnail

D2.347 - Allergen-Specific T Cells to House Dust Mite are absent on the circulation of local allergic rhinitis patients

Thumbnail

D2.348 - Clinical Course of Hereditary Angioedema Patients Transitioning off Androgens

Thumbnail

D2.349 - Hereditary Angioedema in Bulgaria: an update on patient characteristics and treatment modalities

Thumbnail

D2.350 - CVID: the crossroad between immune dysregulation, autoimmunity and cancer

Thumbnail

D2.430 - Two cases of acquired angioedema: one with splenic lymphoma and the other with Waldenström’s macroglobulinemia

Thumbnail

D2.431 - Association of serum IgE levels and atopic status with cancer in the general population

Thumbnail

D2.433 - AllergoOncology: Immunocompetent 3D and Skin Organoid Models of Melanoma to Investigate Tumour-Immune Interactions and Immunotherapies

Thumbnail

D2.434 - AllergoOncology: Novel crusade for Basophil Activation Test

Thumbnail

D2.432 - Blood morphology in health & cancer: comparative, preliminary study on 783 patients

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study

Thumbnail

D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy